Your session is about to expire
← Back to Search
Intrauterine Device
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
Phase < 1
Waitlist Available
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Approved for 10 Other Conditions
All Individual Drugs Already Approved
No Placebo-Only Group
Summary
This trial will compare the expulsion and discontinuation rates of postpartum intrauterine devices (IUDs) placed immediately after delivery versus IUDs placed during a follow-up visit.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Expulsion of intrauterine contraception
Secondary study objectives
Discontinuation of intrauterine contraception
Awards & Highlights
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Contraceptive MirenaExperimental Treatment1 Intervention
Determination of expulsion and discontinuation rates in participants randomly allocated to receive levonorgestrel intrauterine systems Mirena Intrauterine System
Group II: Contraceptive KyleenaExperimental Treatment1 Intervention
Determination of expulsion and discontinuation rates in participants randomly allocated to receive levonorgestrel intrauterine systems Kyleena Intrauterine System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Levonorgestrel
FDA approved
Levonorgestrel
FDA approved
Find a Location
Who is running the clinical trial?
University of OklahomaLead Sponsor
474 Previous Clinical Trials
93,663 Total Patients Enrolled
Valorie Owens, MSWStudy DirectorUniversity of Oklahoma